Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays-论文-万方医学网

首页> > Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays

Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays

导出原文传递

翻译打印收藏纠错

第一作者： Gupta, Yash

作者： Gupta, Yash ^[1] ; Maciorowski, Dawid ^[2] ; Zak, Samantha E. ^[3] ; Jones, Krysten A. ^[4] ; Kathayat, Rahul S. ^[5] ; Azizi, Saara-Anne ^[6] ; Mathur, Raman ^[7] ; Pearce, Catherine M. ; Ilc, David J. ; Husein, Hamza ; Herbert, Andrew S. ; Bharti, Ajay ; Rathi, Brijesh ; Durvasula, Ravi ; Becker, Daniel P. ; Dickinson, Bryan C. ; Dye, John M. ; Kempaiah, Prakasha

作者单位： Infect Dis,Mayo Clin ^[1] Loyola Univ Chicago ^[2] US Army Med Res Inst Infect Dis ^[3] Dept Chem,Univ Chicago ^[4] Geneva Fdn ^[5] Dept Med,Univ Calif San Diego ^[6] Hansraj Coll,Univ Delhi ^[7]

发布时间 2022-06-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays

相似文献

同项目论文

相关期刊

检索历史 清除

Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays

相似文献

同项目论文

相关期刊

检索历史清除